4DMedical is trading 5.22% down at A$3.45 now, with no clearly identified company-specific catalyst for the August 31, 2026 move.
- It released FY2026 results on August 28: A$7.1 million revenue, 21% growth and A$278 million cash; the announcement did not link results to the decline.
- Broader markets were not sufficiently weak to establish a macro-driven explanation, and the August 28 close was unchanged at A$3.64.
- The reason remains unclear.